Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Katila

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Schizophrenia Research|August 30, 2000
Inverse correlation between hallucinations and serum prolactin in patients with non-affective psychosesB Appleberg, H Katila, R Rimón
Molecular Psychiatry|April 20, 1999
Polymorphisms of the interleukin-1 gene complex in schizophreniaH Katila, K Hänninen, M Hurme
Psychosomatic Medicine|October 8, 1997
Plasma interleukin-1 beta and sleep architecture in schizophrenia and other nonaffective psychosesB Appelberg, H Katila, R Rimon
Schizophrenia Research|August 29, 1997
No differences in phospholipase-A2 activity between acute psychiatric patients and controlsH Katila, B Appelberg, R Rimón
The American Journal of Psychiatry|November 4, 2000
Disability pension for major depression in FinlandE T Isometsä, H Katila, T Aro
Journal of Interferon Research|June 1, 1993
Is there a seasonal variation in the interferon-producing capacity of healthy subjects?H Katila, K Cantell, B Appelberg, et al.
Schizophrenia Research|July 1, 1989
Production of interferon-alpha and gamma by leukocytes from patients with schizophreniaH Katila, K Cantell, S Hirvonen, et al.
Schizophrenia Research|April 1, 1994
Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disordersH Katila, B Appelberg, M Hurme, et al.
Neuropsychobiology|January 1, 1994
Plasma and cerebrospinal fluid interleukin-1 beta and interleukin-6 in hospitalized schizophrenic patientsH Katila, M Hurme, K Wahlbeck, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 1, 1991
Plasma concentrations of remoxipride and haloperidol in relation to prolactin and short-term therapeutic outcome in schizophrenic patientsR L Lahdelma, B Appelberg, K Kuoppasalmi, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Schizophrenia Research|August 30, 2000
Inverse correlation between hallucinations and serum prolactin in patients with non-affective psychosesB Appleberg, H Katila, R Rimón
Molecular Psychiatry|April 20, 1999
Polymorphisms of the interleukin-1 gene complex in schizophreniaH Katila, K Hänninen, M Hurme
Psychosomatic Medicine|October 8, 1997
Plasma interleukin-1 beta and sleep architecture in schizophrenia and other nonaffective psychosesB Appelberg, H Katila, R Rimon
Schizophrenia Research|August 29, 1997
No differences in phospholipase-A2 activity between acute psychiatric patients and controlsH Katila, B Appelberg, R Rimón
The American Journal of Psychiatry|November 4, 2000
Disability pension for major depression in FinlandE T Isometsä, H Katila, T Aro
Journal of Interferon Research|June 1, 1993
Is there a seasonal variation in the interferon-producing capacity of healthy subjects?H Katila, K Cantell, B Appelberg, et al.
Schizophrenia Research|July 1, 1989
Production of interferon-alpha and gamma by leukocytes from patients with schizophreniaH Katila, K Cantell, S Hirvonen, et al.
Schizophrenia Research|April 1, 1994
Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disordersH Katila, B Appelberg, M Hurme, et al.
Neuropsychobiology|January 1, 1994
Plasma and cerebrospinal fluid interleukin-1 beta and interleukin-6 in hospitalized schizophrenic patientsH Katila, M Hurme, K Wahlbeck, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 1, 1991
Plasma concentrations of remoxipride and haloperidol in relation to prolactin and short-term therapeutic outcome in schizophrenic patientsR L Lahdelma, B Appelberg, K Kuoppasalmi, et al.
Pageof 3